« Previous
Next »
Atherosclerosis
Volume 204, Issue 2
, Pages 459-464
, June 2009
Association between IL6 gene variants −174G>C and −572G>C and serum IL-6 levels: Interactions with social position in the Whitehall II cohort
References
- . Interleukin-6 and chronic inflammation. Arthritis Res Ther. 2006;8(Suppl. 2):S3
- . Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis. 2000;148:209–214
- Long term interleukin-6 levels and subsequent risk of coronary heart disease: two prospective studies and a systematic review. PLoS Med. 2008;5:E78
- Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab. 1997;82:4196–4200
- Low-grade inflammation, obesity, and insulin resistance in adolescents. J Clin Endocrinol Metab. 2007;92:4569–4574
- . Interleukin-6 and diabetes: the good, the bad, or the indifferent?. Diabetes. 2005;54(Suppl. 2):S114–S124
- Adult socioeconomic position, C-reactive protein and interleukin-6 in the Whitehall II prospective study. Eur J Epidemiol. 2007;22:675–683
- Social and psychosocial influences on inflammatory markers and vascular function in civil servants (the Whitehall II study). Am J Cardiol. 2003;92:984–987
- . Genetic and environmental contributions to plasma C-reactive protein and interleukin-6 levels—a study in twins. Genes Immun. 2006;7:600–605
- . Inter-relationships of interleukin-6, cardiovascular risk factors and the metabolic syndrome among older men. J Thromb Haemost. 2007;5:1637–1643
- The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998;102:1369–1376
- Effect of Interleukin-6 promoter polymorphisms in survivors of myocardial infarction and matched controls in the North and South of Europe. The HIFMECH Study. Thromb Haemost. 2004;92:1122–1128
- . Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem. 2000;275:18138–18144
- Interleukin-6 gene −174g>c and −572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol. 2001;21:1458–1463
- In the elderly, interleukin-6 plasma levels and the −174G>C polymorphism are associated with the development of cardiovascular disease. Arterioscler Thromb Vasc Biol. 2002;22:2066–2071
- Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation. 2001;103:2260–2265
- Role of interaction between variants in the PPARG and interleukin-6 genes on obesity related metabolic risk factors. Exp Gerontol. 2005;40:599–604
- . Interleukin-6 −174G>C polymorphism and risk of coronary heart disease in West of Scotland coronary prevention study (WOSCOPS). Arterioscler Thromb Vasc Biol. 2002;22:599–604
- Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction. Atherosclerosis. 2003;171:359–367
- No association of interleukin-6 gene polymorphism (−174 G/C) with myocardial infarction or traditional cardiovascular risk factors. Int J Cardiol. 2004;97:205–212
- The interleukin-6 G(−174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarction. J Mol Med. 2002;80:507–513
- Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res. 2002;53:1029–1034
- . Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J Clin Endocrinol Metab. 2003;88:255–259
- . Cohort profile: the Whitehall II study. Int J Epidemiol. 2005;34:251–256
- C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance. Diabetes Care. 2005;28:2007–2012
- Serum levels of interleukin-6 (IL-6) are associated with a functional IL6-6331T
>
C polymorphism. Clin Chem. 2008;54:841–850 - . Identification of a novel regulatory region in the interleukin-6 gene promoter. Cytokine. 2008;42:256–264
- . The promoter polymorphism of the interleukin-6 gene regulates interleukin-6 production in neonates but not in adults. Eur Cytokine Netw. 2001;12:62–68
- . Strategy for investigating interactions between measured genes and measured environments. Arch Gen Psychiatry. 2005;62:473–481
- . Gene-environment interaction and its impact on coronary heart disease risk. Nutr Metab Cardiovasc Dis. 2007;17:148–152
- . Evolving methods in genetic epidemiology. III. Gene-environment interaction in epidemiologic research. Epidemiol Rev. 1997;19:33–43
- . Social regulation of gene expression in human leukocytes. Genome Biol. 2007;8:R189
PII: S0021-9150(08)00675-8
doi: 10.1016/j.atherosclerosis.2008.09.019
© 2008 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Atherosclerosis
Volume 204, Issue 2
, Pages 459-464
, June 2009
